TerminatedNot Applicable

Long-term Sequelae of Childhood Meningitis and Meningococcal Purpura Fulminans

Stopped: lack of inclusion

France43 participantsStarted 2021-07-09

Plain-language summary

While the initial evolution of meningococcal meningitis (MM) is well described, there are few data on the long-term evolution, beyond 1 year. The objective of this research is to evaluate the sequelae of MM beyond 1 year in patients with a history of MM followed in Paris area, France. Most children with MM in France have been included in the MM register and are still being followed. Parents will be offered a detailed clinical evaluation of their child including: a clinical and neurological examination, a cognitive performance assessment, an auditory, speech and visual assessment and an evaluation of the child's progress at school.

Who can participate

Age range17 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Infants and children from 0 to 17 years old * Having had meningitis or meningococcal purpura fulminans between 2010 and 2021 * Delay ≥ 1 year between the date of diagnosis of meningitis or purpura meningococcal fulminans and the date of inclusion in the study (signature of the informed consent) * The holders of parental authority have read and understood the information letter and their express consent has been obtained * Patient affiliated to a social security system (Social Security or Universal Medical Coverage) Exclusion Criteria: * refusal to participate

What they're measuring

Number of children with at least one neurological, orthopedic or sensory sequelae

Timeframe: 1 year

Trial details

NCT IDNCT04685850

SponsorCentre Hospitalier Intercommunal Creteil

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2025-05-19

View on ClinicalTrials.gov More Meningitis, Meningococcal trials